<p>In recent decades, aging has sparked growing scientific interest, not only due to the increasing proportion of older adults but also because of the need to understand the complex physiological, cognitive, and emotional changes that accompany this process and determine quality of life in later years. In this context, mild cognitive impairment (MCI) represents an intermediate and potentially reversible stage in the continuum of brain aging, marking a crucial transition between normal cognitive aging and the earliest manifestations of dementia [<span>1</span>]. The most common symptoms of mild cognitive impairment include forgetfulness, difficulty finding words or performing complex tasks, and a reduced ability to plan or make decisions [<span>2</span>]. These often coexist with neuropsychiatric manifestations—such as depression, apathy, or anxiety—that may herald an increased risk of progression to dementia [<span>3</span>]. These affective symptoms are increasingly recognized as key modulators of disease trajectory and functional decline. This dual cognitive and emotional burden underscores the need for comprehensive, non-pharmacological interventions capable of addressing both mind and body.</p><p>The systematic review and meta-analysis by Vásquez-Carrasco et al. [<span>4</span>] offers a timely and rigorous synthesis of current evidence on mindfulness-based interventions in older adults with mild cognitive impairment (MCI). Their findings show that mindfulness training is a feasible, safe, and well-tolerated strategy that significantly alleviates depressive symptoms, although its impact on cognitive outcomes remains uncertain. Beyond its symptomatic benefits, this work highlights mindfulness as an integrative therapeutic approach capable of addressing the intertwined emotional and neurobiological dimensions of aging (Figure 1).</p><p>Mindfulness, understood as the practice of conscious and non-judgmental attention to the present moment, has been shown to induce measurable changes in brain structure and function [<span>5</span>]. Meditation and mindfulness, rooted in ancient traditions, promote mental well-being by cultivating awareness and emotional control. This mental training encourages focused attention on an object, thought, or sensation, thereby strengthening self-regulation and resilience [<span>6</span>]. Neuroimaging studies show increased cortical thickness and enhanced functional connectivity in prefrontal, insular, and anterior cingulate regions—key areas involved in emotional regulation and executive control [<span>6, 7</span>]. At the same time, mindfulness attenuates amygdala reactivity to stress and enhances synchronization between the default mode and executive control networks, processes associated with greater attentional stability and emotional balance [<span>8</span>].</p><p>At the neuroendocrine level, mindfulness training reduces cortisol levels and modulates the hypothalamic–pituitary–adrenal (HPA) axis, promoting phys
{"title":"Mindfulness, Cognition, and Emotional Health in Aging: Beyond the Mind to the Neurobiology of Adaptation","authors":"Paulina Sepúlveda Figueroa","doi":"10.1111/jgs.70262","DOIUrl":"10.1111/jgs.70262","url":null,"abstract":"<p>In recent decades, aging has sparked growing scientific interest, not only due to the increasing proportion of older adults but also because of the need to understand the complex physiological, cognitive, and emotional changes that accompany this process and determine quality of life in later years. In this context, mild cognitive impairment (MCI) represents an intermediate and potentially reversible stage in the continuum of brain aging, marking a crucial transition between normal cognitive aging and the earliest manifestations of dementia [<span>1</span>]. The most common symptoms of mild cognitive impairment include forgetfulness, difficulty finding words or performing complex tasks, and a reduced ability to plan or make decisions [<span>2</span>]. These often coexist with neuropsychiatric manifestations—such as depression, apathy, or anxiety—that may herald an increased risk of progression to dementia [<span>3</span>]. These affective symptoms are increasingly recognized as key modulators of disease trajectory and functional decline. This dual cognitive and emotional burden underscores the need for comprehensive, non-pharmacological interventions capable of addressing both mind and body.</p><p>The systematic review and meta-analysis by Vásquez-Carrasco et al. [<span>4</span>] offers a timely and rigorous synthesis of current evidence on mindfulness-based interventions in older adults with mild cognitive impairment (MCI). Their findings show that mindfulness training is a feasible, safe, and well-tolerated strategy that significantly alleviates depressive symptoms, although its impact on cognitive outcomes remains uncertain. Beyond its symptomatic benefits, this work highlights mindfulness as an integrative therapeutic approach capable of addressing the intertwined emotional and neurobiological dimensions of aging (Figure 1).</p><p>Mindfulness, understood as the practice of conscious and non-judgmental attention to the present moment, has been shown to induce measurable changes in brain structure and function [<span>5</span>]. Meditation and mindfulness, rooted in ancient traditions, promote mental well-being by cultivating awareness and emotional control. This mental training encourages focused attention on an object, thought, or sensation, thereby strengthening self-regulation and resilience [<span>6</span>]. Neuroimaging studies show increased cortical thickness and enhanced functional connectivity in prefrontal, insular, and anterior cingulate regions—key areas involved in emotional regulation and executive control [<span>6, 7</span>]. At the same time, mindfulness attenuates amygdala reactivity to stress and enhances synchronization between the default mode and executive control networks, processes associated with greater attentional stability and emotional balance [<span>8</span>].</p><p>At the neuroendocrine level, mindfulness training reduces cortisol levels and modulates the hypothalamic–pituitary–adrenal (HPA) axis, promoting phys","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"74 2","pages":"313-315"},"PeriodicalIF":4.5,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.70262","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145844647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jose M. Aravena, Hugo Castro, Ronald Poblete, Maria Ines Aravena, Waldo Torres, Paula Vivar, Ester Lara, Marilú Budinich, Patricio Fuentes, Cecilia Albala, Becca R. Levy